Matthew Erickson was diagnosed with a high grade glioma during an ultrasound before birth, but he has defied the odds by his survival. Yet that survival has not been easy; he’s had 11 brain surgeries, 6 rounds of chemotherapy, spent more than 800 days in the hospital (which translates into about half of his life) and endured 1,000 blood draws.
“He lives life as fully as he can,” says his mother, Sue Erickson. “He’s our miracle on earth.”
 |
Living, Not Counting, the Days of SurvivalPaul McDowell shares his 22-year brain tumor story, |
 |
6th Annual Cater to the CureHeld at the Chicago Cultural Center on January 26, 2019 |
Over the last 45 years, many individuals like Matthew and Paul have contributed to the American Brain Tumor Association’s mission. Experience their powerful stories and keep checking back as we build up to the 45 Faces shaping and being impacted by the brain tumor journey.
 |
Research Staff at SNOStaff from the American Brain Tumor Association |
 |
Spring 2019 BT5K ScheduleThe dates and locations for the early spring If you’re ready to sign up or just looking for |
 |
 |
 |
About Meet Hope Head On
Because of the generous support from people like you, the ABTA has given over $35 million for brain tumor research. The ABTA’s campaign, “Meet Hope Head On,” created for our 50th anniversary, is focused on raising $50 million, in part to fund critical brain tumor research. This campaign is vital for continuing the kind of work that led to the recent FDA approval of vorasidenib, a breakthrough treatment for low-grade glioma.
